Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review).
- DOI
- 10.3892/ijo.2026.5932
- Published
- 2026-08-21
- Container
- Int J Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3892/ijo.2026.5932,
title = {Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review).},
author = {Pan J and Li B and Lin R and Fang C and Lau LY and Hong Z and Chen Y.},
year = {2026},
journal = {Int J Oncol},
doi = {10.3892/ijo.2026.5932},
url = {https://doi.org/10.3892/ijo.2026.5932}
}RIS
TY - JOUR TI - Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review). AU - Pan J AU - Li B AU - Lin R AU - Fang C AU - Lau LY AU - Hong Z AU - Chen Y. PY - 2026 JO - Int J Oncol DO - 10.3892/ijo.2026.5932 UR - https://doi.org/10.3892/ijo.2026.5932 ER -
APA
J, P., B, L., R, L., C, F., LY, L., Z, H., & Y., C. (2026). Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review).. Int J Oncol. https://doi.org/10.3892/ijo.2026.5932
Source records
- europe-pmc · retrieved 2026-09-24T23:50:22.778Z